Jesús Vega
PrevMed Care
Jesús Vega is associated with PrevMed Care, focusing on cardiovascular health and stroke prevention. His work centers on identifying warning signs and promoting daily habits to help mitigate the risk of strokes and heart disease.
6 claims checked on air: 5 supported 1 unverified
What they said on air
Pet ownership, particularly owning a dog, helps lower blood pressure.
"And we had a video about 10 ways to lower blood pressure, and one of the latest ways was actually having a pet, having a dog." (said at 0:38:55)
A systematic review and meta-analysis of observational studies examining pet ownership and cardiovascular risk factors found that pet owners had statistically significantly lower systolic blood pressure (mean difference -1.69 mmHg; 95% CI, -3.06 to -0.31) and lower mean arterial pressure (-2.60 mmHg; 95% CI, -4.25 to -0.95) compared to non-pet owners, although diastolic blood pressure and overall hypertension prevalence showed no significant differences. Narrative reviews of the literature similarly note that pet ownership, particularly dog ownership, is associated with lower blood pressure, attenuated cardiovascular reactivity to stress, and increased physical activity, though existing observational data include some conflicting findings.
Scientific research shows that cinnamon has an impact on lowering or regulating blood sugar.
"There's one thing that I'm experimenting with, which is adding cinnamon to the coffee just because I have seen good research on its impact on blood sugar" (said at 1:00:24)
Multiple systematic reviews and meta-analyses of randomized controlled trials (RCTs) confirm that cinnamon supplementation significantly reduces fasting blood glucose levels and insulin resistance, particularly in individuals with type 2 diabetes or prediabetes. While earlier reviews noted high study heterogeneity and conflicting findings regarding long-term hemoglobin A1c (HbA1c) control, updated meta-analyses demonstrate consistent short- to medium-term reductions in fasting blood sugar.
- context: Cinnamon for diabetes mellitus. (The Cochrane database of systematic reviews 2012) · cited 121x in the literature
"The effect of cinnamon on fasting blood glucose level was inconclusive. No statistically significant difference in glycosylated haemoglobin A1c (HbA1c), serum insulin or postprandial glucose was found between cinnamon and control groups." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. (Annals of family medicine 2013) · cited 269x in the literature
"In a meta-analysis of 10 RCTs (n = 543 patients), cinnamon doses of 120 mg/d to 6 g/d for 4 to 18 weeks reduced levels of fasting plasma glucose (-24.59 mg/dL; 95% CI, -40.52 to -8.67 mg/dL)" (abstract, results, passage verified)
pubmedfull study (doi) - supports: Efficacy and safety of cinnamon in type 2 diabetes mellitus and pre-diabetes patients: A m… (Diabetes research and clinical practice 2019) · cited 90x in the literature
"Cinnamon significantly reduced fasting blood glucose (FBG) and homeostatic model assessment for insulin resistance (HOMA-IR) level compared to placebo with weighted mean difference (WMD) of -0.545 (95% CI: -0.910, -0.18) mmol/L, I 2 = 83.6% and -0.714(-1.388, -0.04), I 2 = 84.4% respectively." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The effect of cinnamon supplementation on glycemic control in patients with type 2 diabete… (Phytotherapy research : PTR 2024) · cited 43x in the literature
"Findings from 24 RCTs revealed that cinnamon supplementation had a statistically significant reduction in fasting blood sugar (SMD: -1.32; 95% CI: -1.77, -0.87, p < 0.001), Homeostatic Model Assessment for Insulin Resistance (SMD: -1.32; 95% CI: -1.77, -0.87, p < 0.001), and hemoglobin A1C (SMD: -0.67; 95% CI: -1.18, -0.15, p = 0.011) compared with the control group in patients with T2DM." (abstract, results, passage verified)
pubmedfull study (doi)
Metabolic disease and high blood pressure together cause the majority of strokes.
"the two together—metabolic disease and high blood pressure, they're tied. So they both cause the majority of strokes." (said at 1:04:26)
Large-scale epidemiological studies confirm that hypertension and metabolic conditions (including abdominal obesity, dyslipidemia, and diabetes) together account for the majority of the population attributable risk (PAR) for stroke worldwide. In the global INTERSTROKE study (26,919 participants across 32 countries), hypertension alone accounted for 47.9% of the PAR for all stroke, and combined with cardiometabolic factors (such as waist-to-hip ratio, abnormal lipid ratios, and diabetes), they represent the predominant drivers of stroke risk.
- supports: Global and regional effects of potentially modifiable risk factors associated with acute s… (Lancet (London, England) 2016) · cited 2269x in the literature
"Previous history of hypertension or blood pressure of 140/90 mm Hg or higher (OR 2·98, 99% CI 2·72-3·28; PAR 47·9%, 99% CI 45·1-50·6)... waist-to-hip ratio (1·44, 1·27-1·64 for highest vs lowest tertile; 18·6%, 13·3-25·3 for top two tertiles vs lowest)... apolipoprotein (Apo)B/ApoA1 ratio (1·84, 1·65-2·06 for highest vs lowest tertile; 26·8%, 22·2-31·9 for top two tertiles vs lowest tertile)... and diabetes mellitus (1·16, 1·05-1·30; 3·9%, 1·9-7·6) were associated with all stroke." (abstract, results)
pubmedfull study (doi)
Atrial fibrillation is the leading heart disease issue causing strokes.
"the number one heart disease issue causing strokes, which is atrial fibrillation." (said at 1:04:50)
Atrial fibrillation (AF) is widely established as the leading cardiac cause of stroke (cardioembolic stroke), accounting for approximately 15% to 30% of all ischemic strokes and the majority of strokes originating from a cardiac source.
Atrial fibrillation forms clots in the upper chambers of the heart, which can then travel into the lower chambers and be pumped to the brain.
"Atrial fibrillation is basically an abnormal rhythm of the heart where you create a pool of clots in the upper chambers of the heart, and then one of those can go into the bottom chambers and get pumped into the brain." (said at 1:04:57)
The speaker accurately describes the classic cardioembolic mechanism of ischemic stroke caused by atrial fibrillation (AF). In AF, rapid, disorganized electrical activity causes ineffective mechanical contraction and stasis of blood in the left atrium (particularly in the left atrial appendage), leading to thrombus (clot) formation. A clot or clot fragment can detach, pass from the left atrium through the mitral valve into the left ventricle (the bottom chamber), and then be ejected into the systemic arterial circulation to cause an ischemic stroke in the brain.
- supports: Neurological complications of cardiac disease (heart brain disorders). (Minerva medica 2016) · cited 13x in the literature
"Cardiac emboli can be of different material and derive from the left atrium, left atrial appendage, left ventricle, or the mitral or aortic valves. Also arrhythmias such as atrial fibrillation or atrial flutter may give rise to thrombus formation." (abstract, passage verified)
pubmed - supports: Atrial Fibrillation: An Update for Home Healthcare Clinicians. (Home healthcare now ) · cited 1x in the literature
"The erratic beating of the atria can cause blood clots to form in the atria, and if released into the circulation, an embolism can travel to the brain, causing a stroke." (abstract, passage verified)
pubmedfull study (doi) - supports: Imaging and biophysical modelling of thrombogenic mechanisms in atrial fibrillation and st… (Frontiers in cardiovascular medicine 2022) · cited 46x in the literature
"Atrial fibrillation (AF) underlies almost one third of all ischaemic strokes, with the left atrial appendage (LAA) identified as the primary thromboembolic source." (abstract, passage verified)
pubmedfull study (doi)
Dr. Brewer controlled his atrial fibrillation by losing 10 to 15 pounds.
"Dr. Brewer was able to control his AFib by losing 10 to 15 pounds, and for a lot of people that's more than enough." (said at 1:07:40)
No published record matching the personal case report of Dr. Brewer controlling his atrial fibrillation through a 10 to 15-pound weight loss was located; this does not prove the claim false. While clinical trials and observational cohorts (such as the LEGACY and REVERSE-AF studies) demonstrate that weight loss and risk factor management significantly reduce atrial fibrillation burden and symptom severity in overweight or obese patients, no peer-reviewed documentation of this specific individual case exists in the medical literature.
Fact-checked episodes
Publications
No PubMed publication profile has been built for this speaker yet.